chitosan has been researched along with Respiratory Syncytial Virus Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Guo, M; Liu, C; Peng, J; Shen, X; Tao, L; Wang, Q; Zhang, K | 1 |
| Chen, W; Chen, Z; Cyr, T; Gravel, C; Larocque, L; Li, C; Li, X; Muralidharan, A; Rosu-Myles, M; Russell, MS; Sauvé, S; Wang, L | 1 |
| Bedi, R; Bird, GH; Boyapalle, S; Crannell, WC; Devareddy, A; Mohapatra, S; Mohapatra, SS; Nguyen, H; Opoku-Nsiah, K; Perry, AF; Sampayo, V; Walensky, LD; Wong, T | 1 |
| Coaker, H | 1 |
| Behera, AK; Bhullar, G; Chen, LC; De La Cruz, CP; Huang, SK; Kumar, M; Leong, KW; Lockey, RF; Mohapatra, SS; Zhang, J | 1 |
| Mohapatra, SS | 1 |
1 review(s) available for chitosan and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus.
Topics: Antigens, Viral; Biocompatible Materials; Child; Child, Preschool; Chitin; Chitosan; DNA, Viral; Humans; Infant; Infant, Newborn; Mucous Membrane; Plasmids; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Viral Load; Viral Vaccines | 2003 |
5 other study(ies) available for chitosan and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Development of Inhalable Chitosan-Coated Oxymatrine Liposomes to Alleviate RSV-Infected Mice.
Topics: Animals; Child; Child, Preschool; Chitosan; Humans; Infant; Liposomes; Lung; Matrines; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human | 2022 |
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
Topics: Animals; Antibodies, Neutralizing; Chitosan; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; T-Lymphocytes; T-Lymphocytes, Regulatory | 2019 |
Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection.
Topics: Animals; Cell Line; Chitosan; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Nanoparticles; Nose Diseases; Peptides; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Fusion Proteins | 2014 |
Double-stapled respiratory syncytial virus may prevent nasopulmonary infection.
Topics: Chitosan; Humans; Nanoparticles; Nose Diseases; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Fusion Proteins | 2014 |
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection.
Topics: Animals; Antigens, Viral; Biopolymers; Chitin; Chitosan; Drug Carriers; Female; Genetic Therapy; Genetic Vectors; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Plasmids; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; T-Lymphocytes, Cytotoxic; Vaccines, DNA; Viral Load; Viral Vaccines | 2002 |